person

Jose Juan I.

Country
Spain
Department
Medical Oncology

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
4
Sites with multiple studies

Has run more than one trial at 4 of 113 partner sites.

Specializations

Advanced Breast Cancer Research

The investigator specializes in treating hormone receptor-positive (HR+) and HER2-negative breast cancer, with particular focus on advanced and metastatic cases. Their research encompasses innovative therapeutic approaches using novel combinations of targeted treatments.

  • Metastatic Breast Cancer Management
  • Endocrine Therapy Optimization
  • Advanced Disease Treatment Strategies

Their work extends to evaluating treatments for locally advanced inoperable cases, particularly focusing on hormone receptor-positive disease variants.

Early-Stage Breast Cancer

The investigator conducts research in early-stage breast cancer treatment, with emphasis on adjuvant therapy approaches and quality of life improvements for patients undergoing endocrine treatment.

  • Adjuvant Endocrine Therapy
  • Treatment-Related Symptom Management
  • Disease-Free Survival Enhancement

Their expertise includes developing supportive treatments for managing therapy-related symptoms in early-stage breast cancer patients.

Precision Medicine Applications

The investigator focuses on biomarker-driven treatment approaches and targeted therapies, particularly in the context of specific genetic alterations and molecular pathways.

  • Molecular Pathway Targeting
  • Biomarker Analysis
  • Personalized Treatment Strategies

Their research includes evaluation of novel therapeutic agents targeting specific molecular alterations in breast cancer.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.